Pipeline
Autoimmune diseases
GNR-068
Plaque psoriasis (interleukin inhibitor)
GNR-086
Systemic juvenile idiopathic arthritis (INN: canakinumab)
GNR-087
Rheumatoid arthritis (INN: tocilizumab)
GNR-093
Multiple sclerosis (INN: natalizumab)
Cardiovascular disorders
GNR-060
Myocardial Infarction
Oncology
GNR-084
Acute lymphoblastic leukemia (bispecific antibody, T-cells engager)
GNR-051
Solid tumors (PD-1 inhibitor)
Orphan diseases
GNR-055
MPS II, Hunter syndrome
GNR-062
Fabry disease (INN: agalsidase beta)
GNR-071
Maroteaux-Lamy syndrome, Mucopolysaccharidosis type VI (INN: galsulfase)